Janagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Metformin
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Janagliflozin compared to
placebo, both in combination with Metformin, in Chinese patients with type 2 diabetes
mellitus (T2DM) inadequately controlled with Metformin alone.